Wells Fargo said in a July 19 note that the acquisition is likely under FTC scrutiny, the report said. Reports from Capitol Forum also said the deal could give physicians fewer options for medical devices.
The deal spread widened from $2.87 to $3.31, according to Seeking Alpha. Shareholders from Globus Medical and NuVasive approved the deal in April.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
